FDA Food EnforcementMedium / 中

Imu-Tek Colostrum-5 120 Capsules; 30% IgG, 2 capsules 2x/day, orally with 8 ounces of water, support a healthy immune system, 3 year shelf life, plastic bottle, inner liner seal and shrink band seal, 500 mg capsule, 7 38654 00026 7, Imu-Tek, Inc. Ft. Collins, CO 80524.

Recall H-0660-2026Published 2026-04-08Company Imu-Tek Animal Health, Incorporated
Reason / 召回原因Product is potentially under-processed.
Distribution / 销售地区Product distributed in the following states: AK, AL, AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MA, MD, MO, MS, NC, NE, NH, NV, NY, OK, OR, SC, TN, TX, UT, WA, WI, WY.
Code information / 批次信息Lot #013, 092826 Expiration
i

Official-information notice / 官方信息说明
This page organizes fields from the named agency record. It is not medical, legal, or food-safety advice. Always compare your package with the official notice.

Official record details

官方记录详情:以原始机构公告为准

Recall number / 召回编号

H-0660-2026

Classification / 风险等级

Medium / 中

Published / 发布时间

2026-04-08

Recalling firm / 召回企业

Imu-Tek Animal Health, Incorporated

Product description / 产品描述

Imu-Tek Colostrum-5 120 Capsules; 30% IgG, 2 capsules 2x/day, orally with 8 ounces of water, support a healthy immune system, 3 year shelf life, plastic bottle, inner liner seal and shrink band seal, 500 mg capsule, 7 38654 00026 7, Imu-Tek, Inc. Ft. Collins, CO 80524.

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Lot #013, 092826 Expiration

Product quantity / 产品数量

1003 botlles

Distribution / 销售地区

Product distributed in the following states: AK, AL, AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MA, MD, MO, MS, NC, NE, NH, NV, NY, OK, OR, SC, TN, TX, UT, WA, WI, WY.

Reason for recall / 召回原因

Product is potentially under-processed.

Need the original notice?
Open the agency source for the complete official notice and any disposal, return, or contact instructions.

Open official source ↗

← Return to Recall Radar search / 返回搜索雷达

Last synchronized: 2026-08-09. Recall Radar does not replace agency guidance.